Top-News
Gesundheitswesen: Ausstattung u. Produkte Schweiz

Kuros Biosciences Aktie

Aktie
WKN:  A2ALS5 ISIN:  CH0325814116 US-Symbol:  CSBTF
28,38 CHF
+1,66 CHF
+6,21%
30,386 € 02.05.25
Depot/Watchlist
Aktienanzahl *
37,57 Mio.
Marktkapitalisierung *
1,04 Mrd. €
Streubesitz
53,40%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 25.11.2024

Kuros Biosciences News

15.04.25 - GlobeNewswire
Annual General Meeting of Kuros Biosciences approves all resolutions
Annual General Meeting of Kuros Biosciences approves all resolutions Schlieren (Zurich), Switzerland, April 15, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next ...
15.04.25 - GlobeNewswire
Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025 Financial & ...
11.03.25 - GlobeNewswire
Kuros Biosciences grows sales to CHF 75.6 million for 2024
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences grows sales to CHF 75.6 million for 2024 Financial Highlights Direct MagnetOs™ sales ...
07.01.25 - EQS
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
Kuros Biosciences AG / Key word(s): Agreement Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division 07-Jan-2025 / 07:00 ...
01.12.24 - Boersia.de
Kuros Biosciences Aktie: Im Dialog mit dem Markt
Die Kuros Biosciences-​Aktie zeigt zum Jahresende 2024 eine deutliche Schwankungsbreite im Handel an der SIX Swiss Exchange. Der Biotechnologie-​Titel bewegte sich zuletzt ...
19.11.24 - EQS
Kuros Biosciences Expands into Extremities Markets
Kuros Biosciences AG / Key word(s): Miscellaneous/Personnel Kuros Biosciences Expands into Extremities Markets 19.11.2024 / 07:00 CET/CEST
09.11.24 - Börse-Global
Kuros Biosciences Aktie: Erfolgreiche strategische Schritte!
Die Kuros Biosciences Aktie verzeichnete am Freitag, den 9. November 2024, einen Rückgang von 1,6 Prozent auf 27,95 CHF an der SIX Swiss Exchange. Dieser Abwärtstrend ...
17.10.24 - Boersia.de
Kuros Biosciences Aktie: Starke Kursschwankungen diese Woche
Die Aktie von Kuros Biosciences zeigt in dieser Woche eine hohe Volatilität am Schweizer Aktienmarkt. Am Mittwochnachmittag verzeichnete das Papier einen Rückgang von 0,7 ...
10.10.24 - Boersify
Kuros Biosciences Aktie: Rekordumsatz und Cashflow-Meilenstein erreicht
Kuros Biosciences, ein führendes Unternehmen im Bereich fortschrittlicher Knochenheilungstechnologien, verzeichnete in den ersten neun Monaten des Jahres 2024 einen ...
10.10.24 - EQS
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
Kuros Biosciences AG / Key word(s): Quarter Results Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024 10-...
08.08.24 - EQS
Kuros Biosciences Reports First Half of 2024 Results
Kuros Biosciences AG / Key word(s): Half Year Results Kuros Biosciences Reports First Half of 2024 Results 08-Aug-2024 / 07:00 CET/CEST Release of an ad hoc announcement ...
25.06.24 - EQS
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences AG / Key word(s): Study results/Scientific publication Kuros Biosciences Announces Peer-​Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in ...
24.04.24 - EQS
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
Kuros Biosciences AG / Key word(s): Quarter Results/Regulatory Approval Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales 24-Apr-...
17.04.24 - EQS
Annual General Meeting of Kuros Biosciences approves all resolutions
Kuros Biosciences AG / Key word(s): AGMEGM Annual General Meeting of Kuros Biosciences approves all resolutions 17.04.2024 / 14:05 CET/CEST
13.03.24 - EQS
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
Kuros Biosciences AG / Key word(s): Annual Results Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023 13-...
08.03.24 - EQS
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
Kuros Biosciences AG / Key word(s): Annual Results Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update 08.03.2024 / 07:00 CET/CEST
01.02.24 - EQS
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
Kuros Biosciences AG / Key word(s): Conference Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference 01.02.2024 / 07:00 CET/CEST
31.01.24 - EQS
Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
Kuros Biosciences AG / Key word(s): Regulatory Admission/Market Launch Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and ...
04.01.24 - EQS
Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA
Kuros Biosciences AG / Key word(s): Study results/Preliminary Results Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including ...
27.12.23 - EQS
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
Kuros Biosciences AG / Key word(s): Study/Study results Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA 27-Dec-...

Newssuche

Videos

newspaper
30.04.25 +22,47%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »